Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Kempski

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Innere Medizin (Heidelberg, Germany)|August 31, 2022
[Role of the gut microbiome in the pathogenesis and treatment of inflammatory bowel diseases]Jan Kempski, Samuel Huber
Frontiers in Immunology|November 10, 2017
T<sub>H</sub>17 Cell and Epithelial Cell Crosstalk during Inflammatory Bowel Disease and CarcinogenesisJan Kempski, Leonie Brockmann, Nicola Gagliani, et al.
Hepatology (Baltimore, Md.)|January 22, 2025
PSC and colitis: A complex relationshipLudwig J Horst, Jan Kempski, Martine Walmsley, et al.
The FEBS Journal|January 15, 2021
Rationalizing heptadecaphobia: T<sub>H</sub> 17 cells and associated cytokines in cancer and metastasisJöran Lücke, Ahmad Mustafa Shiri, Tao Zhang, et al.
Viruses|January 28, 2026
Extended Duration of Anti-HEV IgM Seropositivity in Asymptomatic Blood Donors: Implications for Transfusion SafetyJan Kempski, Maria Mader, Samuel Huber, et al.
Scientific Reports|April 2, 2025
Overexpression of Tn antigen induces chronic pancreatitis in miceBaris Mercanoglu, Nina Schraps, Anastasios D Giannou, et al.
Infection|November 25, 2024
Reply to: Challenges in interpreting the role of gentamicin in treatment of invasive listeriosis: immortal timebias and confoundingJan P Sutter, Lorenz Kocheise, Jan Kempski, et al.
Infection|July 4, 2024
Gentamicin combination treatment is associated with lower mortality in patients with invasive listeriosis: a retrospective analysisJan P Sutter, Lorenz Kocheise, Jan Kempski, et al.
Plos One|April 17, 2020
Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomasKarl-Frederick Karstens, Jan Kempski, Anastasios D Giannou, et al.
Frontiers in Immunology|March 21, 2024
A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitisFriederike Stumme, Niklas Steffens, Babett Steglich, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Innere Medizin (Heidelberg, Germany)|August 31, 2022
[Role of the gut microbiome in the pathogenesis and treatment of inflammatory bowel diseases]Jan Kempski, Samuel Huber
Frontiers in Immunology|November 10, 2017
T<sub>H</sub>17 Cell and Epithelial Cell Crosstalk during Inflammatory Bowel Disease and CarcinogenesisJan Kempski, Leonie Brockmann, Nicola Gagliani, et al.
Hepatology (Baltimore, Md.)|January 22, 2025
PSC and colitis: A complex relationshipLudwig J Horst, Jan Kempski, Martine Walmsley, et al.
The FEBS Journal|January 15, 2021
Rationalizing heptadecaphobia: T<sub>H</sub> 17 cells and associated cytokines in cancer and metastasisJöran Lücke, Ahmad Mustafa Shiri, Tao Zhang, et al.
Viruses|January 28, 2026
Extended Duration of Anti-HEV IgM Seropositivity in Asymptomatic Blood Donors: Implications for Transfusion SafetyJan Kempski, Maria Mader, Samuel Huber, et al.
Scientific Reports|April 2, 2025
Overexpression of Tn antigen induces chronic pancreatitis in miceBaris Mercanoglu, Nina Schraps, Anastasios D Giannou, et al.
Infection|November 25, 2024
Reply to: Challenges in interpreting the role of gentamicin in treatment of invasive listeriosis: immortal timebias and confoundingJan P Sutter, Lorenz Kocheise, Jan Kempski, et al.
Infection|July 4, 2024
Gentamicin combination treatment is associated with lower mortality in patients with invasive listeriosis: a retrospective analysisJan P Sutter, Lorenz Kocheise, Jan Kempski, et al.
Plos One|April 17, 2020
Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomasKarl-Frederick Karstens, Jan Kempski, Anastasios D Giannou, et al.
Frontiers in Immunology|March 21, 2024
A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitisFriederike Stumme, Niklas Steffens, Babett Steglich, et al.
Pageof 4